00000nam 2200000zi 4500 9.921681 CaOODSP 20240521150938 m o d f cr ||||||||||| 230414e20240521onc ob f000 0 eng d 9780660483740 CaOODSP eng rda CaOODSP n-cn--- H139-49/2024E-PDF Annex 1 to the Good manufacturing practices guide : manufacture of sterile drugs (GUI-0119). Version 2. [Ottawa] : Health Canada = Santé Canada, 21 May, 2024. ©2024 1 online resource (84 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Annexe 1 des Lignes directrices sur les bonnes pratiques de fabrication : fabrication de médicaments stériles (GUI-0119). "Replaces: Annex 1 to the Good manufacturing practices guide: Manufacture of sterile drugs (GUI-0119), February 28, 2018." Includes bibliographical references (page 81). "This document provides guidance for fabricating and packaging/labelling sterile drugs"--Purpose, page 5. Drug factories Canada. Drugs Sterilization Canada. Drugs Labeling Canada. Canada. Health Canada, issuing body. Annexe 1 des Lignes directrices sur les bonnes pratiques de fabrication : (CaOODSP)9.921682 PDF 820 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H139-49-2024-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-annex-1-manufacture-sterile-drugs-0119.html 240207